Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 233 posts found.

teva_small

Teva job cut rumours resurface, 10,000 expected

December 11, 2017
Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have …

News
teva_copy

Teva looks set to axe thousands of positions and a big name

November 23, 2017
Manufacturing and Production Teva, biotech, drugs, pharma, pharmaceutical

Teva’s troubled year needs little detailing, those following the company have seen it lurch from one piece of bad news …

News

Teva’s woes continue, as shares sink to 17-year low on Q3 results

November 2, 2017
Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …

News

Allergan ready to take a loss by selling Teva shares

November 2, 2017
Sales and Marketing Allergan, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Allergan sold its generic business to Teva back in August 2016 for a sum of $33 billion and 100 million …

News

CEO and President implicated as price-fixing probe widens

November 1, 2017
Research and Development, Sales and Marketing Mylan, Teva, biotech, drugs, pharma, pharmaceutical

A group of states, 45 members-strong, has expanded its probe into the generics pharmaceutical industry by expanding its case to …

News
teva_copy

Teva under investigation over illegal rebate offers to Ontario pharmacies

October 20, 2017
Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone

Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …

News
mylan_building_3

Mylan receives shock approval of Teva blockbuster

October 5, 2017
Sales and Marketing Copaxone, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …

News
teva_copy

Teva completes sale of women’s health for $1.38 billion

September 19, 2017
Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health

Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cosentyx, Eli Lilly, Martin Skreli, Teva, pharma, top ten

This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …

News

Teva announces sale of Paragard for $1.1 billion

September 12, 2017
Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical

Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …

News
29863293981_33b910b458_z

Teva finally announces successful CEO appointment

September 11, 2017
Medical Communications, Sales and Marketing Lundbeck, Teva, biotech, drugs, pharma, pharmaceutical

Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …

News
teva

Teva scores expanded indication for Austedo in tardive dyskinesia

August 31, 2017
Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals

Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …

News
francesa

US Congressmen accuse Teva of price hikes over 1,000%

August 21, 2017
Sales and Marketing Copaxone, Teva, life sciences, medicine, multiple sclerosis, pharma, pharmaceutical, price hiking

A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of …

News
teva_canada

Teva releases financials, shares fall off cliff, plans to axe 7000 jobs

August 3, 2017
Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

Teva has released its second quarter financials and they do not make for great reading if you’re an investor. The …

News
sanofi-steve-oldfield

Department of Health appoints Teva and Sanofi veteran as commercial head

July 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, Sanofi, Teva, biotech, drugs, government, healthcare, pharma, pharmaceuticals

The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …

Appointment

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023